The global embolic protection devices market size is expected
to reach USD 1.7 billion by 2026, according to a new report by Grand View
Research, Inc. The market is estimated to expand at a CAGR of 8.4% during the
forecast period. Rising incidences of cardiovascular and neurovascular diseases
and growing adoption of minimally invasive diseases are propelling the market
growth. Rising demand for technologically advanced embolic devices and
increasing healthcare expenditure, resulting in huge funding and investments
from multinational companies, are fueling the R&D in the global medical
devices industry. This factor is also contributing toward the market growth.
On the other hand, the product failures and
recalls may limit the market growth. Low reimbursement for stenting and
presence of alternative treatment methods, such as the use of drugs, may also
imped the market development. However, factors such as a rise in the number of
Trans-catheter Aortic Valve Replacement (TAVR) procedures will support the
market expansion. The number of TAVR centers in U.S. has increased from 156 in
2012 to 511 in 2017, and approximately 35,000 patients underwent TAVR in 2016 in
U.S. alone. The distal occlusion systems segment is expected to register the
highest CAGR over the forecast period.
For full research report on Embolic
Protection Devices Market visit here: https://www.grandviewresearch.com/industry-analysis/embolic-protection-devices-market
Further key
findings from the study suggest:
- Distal filter devices segment emerged as the
largest segment owing to high demand for these devices
- Neurovascular diseases accounted for the
largest share in the application segment owing to the rising cases of
neurological disorders
- North America led the global embolic
protection devices market with the largest share in 2017 and is likely to
maintain this trend over the estimated period
- Growing adoption of minimally invasive
surgeries and increasing demand for novel technologies are facilitating
the dominance of this region
- The industry in the Asia Pacific is projected
to witness swift growth during the forecast period owing to rapidly
improving healthcare infrastructure and large target population base
- Some of the key companies include Boston
Scientific Corp.; Edward Lifesciences; Abbott Laboratories; Medtronic Plc;
Cardinal Health, Inc.; Claret Medical, Inc.; and Innovative Cardiovascular
Solutions, LLC
Get request sample of this report here: https://www.grandviewresearch.com/industry-analysis/embolic-protection-devices-market/request/rs1
Grand
View Research has segmented the global embolic protection devices market on the
basis of product, application, and region:
Embolic
Protection Devices Product Outlook (Revenue, USD Million, 2014 - 2026)
- Distal Occlusion
Devices
- Proximal Occlusion
Devices
- Distal Filters
Embolic
Protection Devices Application Outlook (Revenue, USD Million, 2014 - 2026)
- Neurovascular
Diseases
- Cardiovascular
Diseases
- Peripheral Vascular
Diseases
Embolic
Protection Devices Regional Outlook (Revenue, USD Million, 2014 - 2026)
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- Asia Pacific
- Japan
- China
- Latin America
- Brazil
- Mexico
- Middle East &
Africa
- South Africa
- Saudi Arabia
About Grand View Research
Grand View Research, Inc. is a U.S. based market research
and consulting company, registered in the State of California and headquartered
in San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
No comments:
Post a Comment